TY - JOUR
T1 - Paracentric inversion-associated t(8;21) variant in de novo acute myelogenous leukemia
T2 - characteristic patterns of conventional cytogenetics, FISH, and multicolor banding analysis
AU - Park, Tae Sung
AU - Song, Jaewoo
AU - Lee, Kyung A.
AU - Min, Yoo Hong
AU - Lee, Sang Guk
AU - Park, Yongjung
AU - Kim, Juwon
AU - Lee, Eun Yup
AU - Choi, Jong Rak
PY - 2008/5
Y1 - 2008/5
N2 - Acute myelogenous leukemia (AML) with t(8;21)(q22;q22) demonstrates unique clinico-pathologic disease entity in patients with hematologic malignancies. The t(8;21), which results in fusion of the AML1 gene on 21q22 and the ETO gene on 8q22 on a molecular level, is one of the most common nonrandom chromosomal changes, and it is found in about 5-12% of patients with AML. Among these cases, complex variants involving chromosomes 8 and 21, as well as a third or fourth chromosome, account for approximately 6-10% of patients with an AML1/ETO chimeric gene, and about 100 variant cases with AML1/ETO fusion transcript have been reported in the literature. Here, we describe a rare case report of reciprocal paracentric inversion-associated t(8;21) variant in a 28-year old male patient with de novo AML. The abnormal results of conventional cytogenetics and interphase fluorescent in situ hybridization in this patient drove us to perform further studies and a literature review. This report emphasizes the value of "conventional" cytogenetics, as well as "newly developed" molecular cytogenetic methods in the diagnosis of rare complex t(8;21) variant in patients with AML.
AB - Acute myelogenous leukemia (AML) with t(8;21)(q22;q22) demonstrates unique clinico-pathologic disease entity in patients with hematologic malignancies. The t(8;21), which results in fusion of the AML1 gene on 21q22 and the ETO gene on 8q22 on a molecular level, is one of the most common nonrandom chromosomal changes, and it is found in about 5-12% of patients with AML. Among these cases, complex variants involving chromosomes 8 and 21, as well as a third or fourth chromosome, account for approximately 6-10% of patients with an AML1/ETO chimeric gene, and about 100 variant cases with AML1/ETO fusion transcript have been reported in the literature. Here, we describe a rare case report of reciprocal paracentric inversion-associated t(8;21) variant in a 28-year old male patient with de novo AML. The abnormal results of conventional cytogenetics and interphase fluorescent in situ hybridization in this patient drove us to perform further studies and a literature review. This report emphasizes the value of "conventional" cytogenetics, as well as "newly developed" molecular cytogenetic methods in the diagnosis of rare complex t(8;21) variant in patients with AML.
UR - http://www.scopus.com/inward/record.url?scp=43049171812&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=43049171812&partnerID=8YFLogxK
U2 - 10.1016/j.cancergencyto.2008.02.003
DO - 10.1016/j.cancergencyto.2008.02.003
M3 - Article
C2 - 18474302
AN - SCOPUS:43049171812
SN - 0165-4608
VL - 183
SP - 72
EP - 76
JO - Cancer genetics and cytogenetics
JF - Cancer genetics and cytogenetics
IS - 1
ER -